We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.55%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.9B
AUM Growth
+$82.9M
(+0.56%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-8.19%
Top 10 Holdings %
Top 10 Hldgs %
17.88%
Holding
1,150
New
131
Increased
316
Reduced
491
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$108M |
| 2 |
AT&T
T
|
+$102M |
| 3 |
Valero Energy
VLO
|
+$70.6M |
| 4 |
Marathon Petroleum
MPC
|
+$53.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$51.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.1M |
| 2 |
Dell
DELL
|
+$87.8M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$85.7M |
| 4 |
General Motors
GM
|
+$85.2M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Healthcare | 14.02% |
| 3 | Consumer Discretionary | 12.92% |
| 4 | Financials | 11.35% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HARP
576
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.47M | 0.02% |
32,681
+23,971
| +275% | +$1.64M |
|
577
Bassett Furniture
BSET
$169M
| $2.46M | 0.02% |
146,882
+1,895
| +1% | +$32.9K |
|
|
DCPH
578
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.46M | 0.02% |
252,017
+231,382
| +1,121% | +$4.35M |
|
|
KE
579
Kimball Electronics
KE
$566M
| $2.45M | 0.02% |
112,731
+18,943
| +20% | +$475K |
|
580
Insight Enterprises
NSIT
$3.84B
| $2.44M | 0.02% |
22,889
-35
| -0.2% | -$3.48K |
|
581
Radiant Logistics
RLGT
$401M
| $2.44M | 0.02% |
334,169
+77,281
| +30% | +$556K |
|
|
CTO
582
CTO Realty Growth
CTO
$762M
| $2.42M | 0.02% |
117,993
-2,664
| -2% | -$49.3K |
|
583
First Financial Corp
THFF
$956M
| $2.41M | 0.02% |
53,301
+366
| +0.7% | +$16.1K |
|
584
STAAR Surgical
STAA
$1.2B
| $2.38M | 0.02% |
26,072
-7,473
| -22% | -$802K |
|
585
AngioDynamics
ANGO
$597M
| $2.36M | 0.02% |
85,590
-3,258
| -4% | -$89.9K |
|
586
Fortive
FTV
$18.2B
| $2.35M | 0.02% |
+40,805
| New | +$2.31M |
|
|
CSLT
587
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.35M | 0.02% |
1,523,248
-500,220
| -25% | -$825K |
|
|
WSR
588
DELISTED
Whitestone REIT
WSR
| $2.34M | 0.02% |
231,427
+4,695
| +2% | +$45.7K |
|
|
STOR
589
DELISTED
STORE Capital Corporation
STOR
| $2.32M | 0.02% |
67,448
| – | – |
|
590
American Vanguard Corp
AVD
$72.1M
| $2.31M | 0.02% |
140,982
+23,686
| +20% | +$371K |
|
591
Evergy
EVRG
$19.5B
| $2.31M | 0.02% |
33,596
-21,072
| -39% | -$1.37M |
|
592
Puma Biotechnology
PBYI
$397M
| $2.3M | 0.02% |
756,675
+313,594
| +71% | +$1.36M |
|
593
Peapack-Gladstone Financial
PGC
$821M
| $2.3M | 0.02% |
64,888
+3,935
| +6% | +$135K |
|
594
Domino's
DPZ
$12B
| $2.29M | 0.02% |
4,055
-79,686
| -95% | -$40.5M |
|
595
Avanos Medical
AVNS
| $2.26M | 0.02% |
65,134
+46,736
| +254% | +$1.51M |
|
596
FMC
FMC
$1.31B
| $2.25M | 0.02% |
20,502
-45,784
| -69% | -$4.6M |
|
597
Titan Machinery
TITN
$426M
| $2.25M | 0.02% |
66,624
-6,010
| -8% | -$187K |
|
|
PSTX
598
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.24M | 0.02% |
328,381
-16,563
| -5% | -$113K |
|
|
JNCE
599
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.23M | 0.01% |
+267,032
| New | +$2.2M |
|
|
IVC
600
DELISTED
Invacare Corporation
IVC
| $2.2M | 0.01% |
809,136
+242,042
| +43% | +$892K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2021 Portfolio in Review
As of Q4 2021, Jacobs Levy Equity Management held 1,150 positions worth $14.9B, up 0.56% from $14.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management withdrew a net $1.22B in Q4 2021, closing 190 positions and reducing 491 holdings. Its most notable exit was Cerner Corp, an estimated $46M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jacobs Levy Equity Management opened a new position in Booking.com worth $109M.
- Jacobs Levy Equity Management's largest Q4 2021 buy was Booking.com: 1,135,900 shares worth $109M.
- Jacobs Levy Equity Management added most to AT&T in Q4 2021, an estimated $102M increase.
- Jacobs Levy Equity Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $89.1M.
- Jacobs Levy Equity Management fully exited Cerner Corp in Q4 2021, selling an estimated $46M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2021.
- Jacobs Levy Equity Management opened 131 new positions and closed 190 in Q4 2021.
- Jacobs Levy Equity Management's portfolio value rose 0.56% quarter-over-quarter to $14.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.